Core Viewpoint - A class action securities lawsuit has been filed against Lantheus Holdings, Inc. for alleged securities fraud affecting investors between February 26, 2025, and August 5, 2025 [1][2] Group 1: Lawsuit Details - The lawsuit claims that Lantheus made false statements and concealed information regarding its revenue outlook and growth potential, particularly related to the product Pylarify [2] - Allegations include that Lantheus misrepresented its understanding of market pricing and competitive dynamics, leading to an overly optimistic sales growth projection for Pylarify [2] Group 2: Investor Information - Investors who suffered losses during the specified period have until November 10, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [4]

Core Viewpoint - A class action securities lawsuit has been filed against Lantheus Holdings, Inc. for alleged securities fraud affecting investors between February 26, 2025, and August 5, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that the defendants made false statements and concealed information regarding the company's revenue outlook and growth potential, particularly related to Pylarify's sales growth and market dynamics [2]. - It is alleged that Lantheus did not accurately understand the pricing and competitive dynamics of Pylarify's market, contrary to the optimistic reports provided by the company [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until November 10, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Insights - The FDA has accepted Lantheus Holdings' New Drug Application for MK-6240, a PET imaging agent for detecting tau pathology in Alzheimer's disease, with a PDUFA target action date set for August 13, 2026 [1][2] Company Overview - Lantheus is a leading radiopharmaceutical-focused company dedicated to improving patient outcomes through innovative diagnostic tools [6] - The company has been providing radiopharmaceutical solutions for nearly 70 years and operates in multiple countries including the U.S., Canada, Germany, Sweden, Switzerland, and the U.K. [6] Product Details - MK-6240 targets aggregated tau protein, a key marker in neurodegenerative diseases, and has shown high affinity for tau with limited off-target binding in studies [5] - The NDA submission for MK-6240 is supported by data from two pivotal Phase 3 clinical trials that met their co-primary endpoints of sensitivity and specificity for detecting tau neurofibrillary tangles [2][5] Market Potential - The U.S. Alzheimer's Disease radiodiagnostic market is projected to exceed 400,000 scans and reach $1.5 billion by 2030, driven by rising prevalence and expanded PET imaging guidelines [4] - There are nearly 12 million people in the U.S. living with mild cognitive impairment or Alzheimer's disease, with projections indicating this number could grow to over 20 million by 2050 [3]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Lantheus Holdings, Inc. during the specified Class Period of the upcoming lead plaintiff deadline on November 10, 2025 [1]. Group 1: Class Action Details - Investors who purchased Lantheus securities between February 26, 2025, and August 5, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - The lawsuit alleges that Lantheus provided misleading statements about its product Pylarify, failing to disclose critical information regarding its competitive position and pricing strategy [5]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own achievements in securing significant settlements for investors [4]. - The firm has been recognized for its success in securities class action settlements, including a notable settlement against a Chinese company and ranking first in the number of settlements in 2017 [4].

Core Points - The Gross Law Firm has issued a notice to shareholders of Lantheus Holdings, Inc. regarding a class action lawsuit related to alleged false statements and omissions concerning the company's revenue outlook and market dynamics [1][2] - The class period for the lawsuit is from February 26, 2025, to August 5, 2025, during which shareholders are encouraged to register for potential recovery [2] - Allegations include that Lantheus misrepresented its understanding of the competitive landscape and pricing dynamics for its product Pylarify, leading to inflated stock prices [1] Company Summary - Lantheus Holdings, Inc. is facing allegations of misleading investors about its sales growth potential and market conditions for Pylarify, which may have resulted in artificial inflation of its stock price [1] - The Gross Law Firm aims to protect investors' rights and seeks recovery for those who suffered losses due to the alleged deceitful practices of Lantheus [3] Next Steps for Shareholders - Shareholders who purchased shares during the specified class period should register by November 10, 2025, to be included in the case and receive updates [2] - There is no cost or obligation for shareholders to participate in the class action lawsuit [2]

Core Viewpoint - A class action lawsuit has been filed against Lantheus Holdings, Inc. for allegedly making materially false and misleading statements regarding its product Pylarify and its competitive position during the specified class period [3][7]. Allegation Details - The lawsuit claims that Lantheus provided overly positive statements while concealing adverse facts about Pylarify's competitive position [3]. - It is alleged that Lantheus was not adequately equipped to assess pricing and competitive dynamics for Pylarify [3]. - The company reportedly failed to disclose that a price increase in early 2025, despite previous price erosion, created opportunities for competitive pricing, jeopardizing Pylarify's price point and growth potential [3]. - As a result, the statements made by the defendants regarding the company's business and prospects were materially false and misleading [3]. Next Steps - Investors who purchased Lantheus shares and suffered losses are encouraged to contact the law firm for more information and to discuss their rights [4][7]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is November 10, 2025 [7].

Core Viewpoint - A class action securities lawsuit has been filed against Lantheus Holdings, Inc. for alleged securities fraud affecting investors between February 26, 2025, and August 5, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Lantheus made false statements and concealed information regarding its revenue outlook and growth potential, particularly related to the sales growth of its product Pylarify [2]. - Allegations include that Lantheus misrepresented its understanding of market pricing and competitive dynamics, leading to an overly optimistic portrayal of its financial prospects [2]. Group 2: Investor Information - Investors who suffered losses during the specified period have until November 10, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, indicating a no-cost participation in the lawsuit [3]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lantheus investors who were adversely affected by alleged securities fraud between February 26, 2025 and August 5, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/lantheus-holdings ...

NEW YORK, Oct. 23, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Lantheus Holdings, Inc. (NASDAQ: LNTH). Accessibility StatementSkip Navigation CONTACT US HERE: Shareholders who purchased shares of LNTH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. https://securitiesclasslaw.com/securities/lantheus-holdings-inc-loss-submission-f ...

BEDFORD, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, November 6, 2025, to discuss its financial results and provide a business update for the third quarter of 2025. To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fift ...